Indian Journal of Medical Microbiology · 2006 · 108 citations · 8 references
Life SciencesInfectious DiseasesMicrobiologyAntimicrobial ResistanceBacteriologyMedical MicrobiologyAntibiotic ResistanceAntimicrobial Susceptibility TestingBacterial EpidemiologyBacterial InfectionsBeta-lactam ResistanceCarbapenem ResistanceCephalosporin ResistanceDisk Diffusion TestingEscherichia ColiExtended-spectrum Beta-lactamase Producing OrganismsExtended-spectrum Beta-lactamase ProductionExtended-spectrum Beta-lactamase-producing OrganismsExtended-spectrum Beta-lactamasesβ-Lactam Antibiotics
Increasing resistance to third generation cephalosporins has become a cause for concern especially among Enterobacteriaceae that cause nosocomial infections. The prevalence of extended spectrum beta-lactamases (ESBLs) among members of Enterobacteriaceae constitutes a serious threat to current beta-lactam therapy leading to treatment failure and consequent escalation of costs. A detailed study was initiated to identify the occurrence of ESBLs among the Enterobacteriaceae isolates at a tertiary care hospital using the double disk potentiation technique. Antibiogram profiles were determined to commonly used antibiotics and confirmation of ESBLs production was carried out by the disk diffusion assay using ceftazidime and cefotaxime in the presence and absence of clavulanic acid. Our results indicate that the majority of ESBLs were expressed in Escherichia coli.
8
Vincent Jarlier, M. H. Nicolas, G. Fournier et al. · Clinical Infectious Diseases · 1988 · 1.6K citations
Kenneth S. Thomson, Christine C. Sanders · Antimicrobial Agents and Chemotherapy · 1992 · 218 citations
Teresa Spanu, Francesco Luzzaro, Mariagrazia Perilli et al. · Antimicrobial Agents and Chemotherapy · 2002 · 170 citations · Full text